Torrent Pharmaceuticals(TRP) is a strong player in chronic segment in India and Unichem acquisition is a strategic fit for the Company as it would further strengthen its presence in key chronic therapy segment. TRP would be able to improve the profitability of Unichem’s product portfolio through its strong field force and distribution network.
INDUSINDBK (PREVIOUS CLOSE: 1676) BUY
Fresh long position can be initiated in the range of Rs1665-1650 for
the target of Rs1755 with a strict stop loss of Rs1615
MARICO (PREVIOUS CLOSE: 310)BUY
For today’s trade, long position can be initiated at around Rs308-306
for the target of Rs315-318 with a strict stop loss of Rs303.
RAYMOND (PREVIOUS CLOSE: 979) SELL
For today’s trade, short position can be initiated at around Rs985-990 for the target of Rs960-950 with a strict stop loss of Rs1000.
Click here to read the full report
About Reliance Securities
Reliance Securities, the broking arm of Reliance Capital, is one of the India’s leading retail broking houses, providing customers with access to equities, derivatives, currency, IPOs, mutual funds, bonds, and corporate FDs amongst others. The large array of financial offerings helps customers fulfilling their investment objectives on one platform. Focus on timely & error-free execution represents its core strength. Their best in class research offerings, high degree of compliance with stock exchange regulations, ethical business standards, & strong risk management capabilities; Reliance Securities positions itself amongst strong & innovative brands in the financial services space.
For more information please write in to email@example.com
Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor IndiaNotes.com accept any liability whatsoever arising from the use of any of the above contents.